ipilimumab,nivolumab,cabozantinib
exelixis,bms
['nivo', 'kcsm,(-skcsm)', 'cabozantinib', 'rcc,(-irccs),(-srcc),(-urcc)', 'ipilimumab', 'nivolumab']
cabozantinib improves pfs outcomes with nivolumab, ipilimumab in advanced rcc #esmo2022 #kcsm #rcc 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.